Clinical Trials

Patient Response Phase I Trials Phase II Trials Precision Medicine Trial Results

New BTC Cell Line Atlas Unveils Molecular Subtypes and Therapeutic Targets

Researchers have developed a publicly accessible atlas of nearly 60 patient-derived biliary tract cancer cell lines, providing a foundation for precision oncology and biomarker-driven clinical trials.

4 ARTICLES

this yr.

FDA Approves Adaptimmune's Groundbreaking T-Cell Therapy for Rare Cancer